Research and Markets: Board Review in Medical Oncology
DUBLIN-(Business Wire)-September 22, 2009 - Research and Markets (http://www.researchandmarkets.com/research/b0e0bb/board_review_in_me) has announced the addition of the "Board Review in Medical Oncology" training to their offering.
The George Washington University Medical Center Robert S. Siegel, MD, Course Chair
The material has been prepared by medical experts specifically trained in hematology and medical oncology in conjunction with The George Washington University Medical Center to help physicians improve their skills.
- Panel of hematology-medical oncology experts to help you prepare for your certification/recertification exam.
- Self-study program lets you learn without the expense of travel or time away from your practice. Repeat lectures as needed to reinforce learning of difficult topics.
Target Audience
This program is designed for the fellow-in-training, the physician planning to take the Medical Oncology certifying or re-certifying examination, or the practitioner of Medical Oncology who wishes to review both established standards of care and recent basic and clinical advances in Medical Oncology.
Learning Objectives
After viewing this program, participants should be able to:
- Understand the epidemiology of malignant diseases and management of the medical complications of malignancy
- Recognize the latest advances in cancers of the lung, the breast, and the gastrointestinal tract
- Understand the principals of management of gynecologic and other genito-urinary malignancies
- Contend with complexity of HIV related malignancies
- Recognize principles of new developments in biologic therapy of cancer
- Be familiar with the diagnosis, evaluation, and management of hematologic malignancies
- Understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs
Accreditation
The George Washington University Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essential Areas, Elements and Policies.
Credit Designation
The George Washington University Medical Center designates this self-study Hematology/Oncology Board Review for a maximum of 32 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The Learning Process Physician learners are expected to view/listen to all modules, reflect on their content, complete the CME self-assessment and CME evaluation, and return them to the address indicated for scoring. A processing fee must accompany the completed self-assessment and evaluation. Only upon receipt of your self-assessment, evaluation and payment will your CME certificate and correct answers to the self-assessment be mailed to you.
Estimated Time to Complete this CME Program: 32 Hours
Method of Physician Participation: Review recordings of conference sessions and apply knowledge to post-test.
Evaluation Methods: Participants will complete a self-assessment examination to test knowledge gained from viewing the program.
Grantors: The live CME activity from which this self-study CME activity is derived was supported in part by educational grants provided by:
BiogenIDEC Cephalon Merck & Co. NovoNordisk Ortho Biotech Oncology OSI Pharmaceuticals Sanofi-Aventis Wyeth
For the full details of speakers and in depth subjects covered, click the link below
http://www.researchandmarkets.com/research/b0e0bb/board_review_in_me
 |
 |
 |
|
||
 |
|
 |
|
||
Search Our News Using Google Search
Can't find what you want? Try using Google:
